AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Glimsay MP 1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Meraki Health

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimsay MP 1 Tablet ER

Diabetic patients benefit from Glimsay MP 1 Tablet ER, a combined medication regulating blood glucose. Used alongside diet and exercise, it enhances blood sugar management in adults with type 2 diabetes by improving insulin effectiveness. Dosage and duration should strictly follow your physician's instructions; ingest with food to minimize gastric distress. Missed doses should be taken promptly unless the next dose is imminent; avoid doubling the dose. Overdosage risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or meal skipping elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor; pregnant or lactating individuals require medical consultation. Pre-treatment kidney function tests are standard. Limit alcohol consumption to mitigate potential side effects.

Uses of Glimsay MP 1 Tablet ER

Managing Type 2 diabetes

Major Benefits of Glimsay MP 1 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or dividing it. Glimsay MP 1 Extended-Release Tablet should be administered with a meal.

Common Side effects of Glimsay MP 1 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimsay MP 1 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimsay MP 1 Extended-Release Tablet should be taken with a meal.

How Glimsay MP 1 Tablet ER works:

Glimsay MP 1 Extended-Release tablet combines three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. These medications employ diverse mechanisms to enhance glycemic control when monotherapy or dual-agent regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose absorption, and augmenting insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimsay MP 1 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimsay MP 1 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Glimsay MP 1 Tablet ER while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimsay MP 1 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimsay MP 1 Tablet ER cautiously, potentially requiring a modified dosage. Physician consultation is advised. Glimsay MP 1 Tablet ER is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimsay MP 1 Tablet ER :

Should you forget a Glimsay MP 1 Tablet ER dose, take it immediately if you remember. But, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimsay MP 1 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimsay MP 1 Tablet ER

Drinking alcohol with Glimsay MP 1 Tablet ER is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Tell your doctor before taking Glimsay MP 1 Tablet ER if you have congestive heart failure, kidney or liver problems, or swelling behind your eye. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you take—prescription or not, including vitamins and herbal supplements.
Metformin, a component of Glimsay MP 1 Tablet ER, can lead to vitamin B12 deficiency with prolonged use due to impaired vitamin B12 absorption in the stomach.
Glimsay MP 1 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a quick-sugar source, such as candy or chocolate.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimsay MP 1 Tablet ER
141
MRP 172
17% off